Skip to main content
Clinical Trials/NL-OMON55566
NL-OMON55566
Completed
Not Applicable

A multi-center randomized controlled study of primary prevention of esophageal variceal bleeding in cirrhotic patients treated with HVPG-guided beta- blocker therapy or standard heart rate-guided beta-blocker therapy. - PORTHOS trial

eids Universitair Medisch Centrum0 sites66 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Esophageal variceal bleeding
Sponsor
eids Universitair Medisch Centrum
Enrollment
66
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Liver cirrhosis
  • Esophageal varices \>\=5 mm, no prior variceal bleeding
  • Patient age 18 years or older

Exclusion Criteria

  • Contraindications to beta\-blocker therapy
  • Prior variceal hemorrhage
  • Esophageal varices in the absence of liver cirrhosis
  • Intermediate, advanced or terminal stage hepatocellular carcinoma (BCLC stage
  • Refractory ascites
  • Hepatorenal syndrome
  • Prior treatment or prophylaxis for esophageal varices or esophageal variceal
  • bleedings (propranolol use, TIPS, endoscopic bandligation, endoscopic
  • sclerotherapy)

Outcomes

Primary Outcomes

Not specified

Similar Trials